Cyproheptadine Hydrochloride
Cyproheptadine Hydrochloride Tablets
Approved
Approval ID
f90faaa3-f40f-4653-8fb8-144d61c6b1d4
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 15, 2026
Manufacturers
FDA
Boscogen, Inc.
DUNS: 932611189
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cyproheptadine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62033-0346
Product Classification
G
Generic Name
Cyproheptadine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 26, 2011
FDA Product Classification
INGREDIENTS (5)
Cyproheptadine HydrochlorideActive
Quantity: 4 mg in 1 1
Code: NJ82J0F8QC
Classification: ACTIB
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Cellulose, MicrocrystallineInactive
Code: OP1R32D61U
Classification: IACT
Lactose MonohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
Sodium Starch Glycolate Type A PotatoInactive
Code: 5856J3G2A2
Classification: IACT